10-K
Annual Report
ADIAL PHARMACEUTICALS, INC.
ADIL
NASDAQ
CIK: 1513525
File #: 001-38323
Balance Sheet
36 line items · 2 periods
XBRL
| Item | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
Current Assets: | ||
Cash and cash equivalents | 2,827,082 | 4,001,794 |
Prepaid expenses and other current assets | 371,597 | 349,441 |
Current assets of discontinued operations | — | 428,700 |
Total Current Assets | 3,198,679 | 4,779,935 |
Discontinued Operations | — | 428,700 |
Intangible assets, net | 3,913 | 4,477 |
Equity method investment | 1,534,013 | — |
Equity Method Investments | 1,534,013 | — |
Assets of discontinued operations | — | 948,392 |
Total Assets | 4,736,605 | 5,732,804 |
Discontinued Operations | — | 1,377,092 |
Current Liabilities: | ||
Accounts payable | 103,325 | 276,410 |
Discontinued Operations | — | 117,424 |
Accounts payable, related party | 24,062 | — |
Accrued expenses | 477,747 | 963,327 |
Discontinued Operations | — | 191,490 |
Accrued expenses, related party | 47,942 | 175,000 |
Other current liabilities | — | 10,387 |
Current liabilities of discontinued operations | — | 365,742 |
Total Current Liabilities | 653,076 | 1,790,866 |
Discontinued Operations | — | 365,742 |
Long-term Liabilities: | ||
Long-term liabilities of discontinued operations | — | 665,444 |
Total Liabilities | 653,076 | 2,456,310 |
Discontinued Operations | — | 1,031,186 |
Stockholders’ Equity | ||
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 1,663,421 and 1,067,491 shares issued and outstanding at December 31, 2023 and 2022, respectively | 1,663 | 1,067 |
Additional paid in capital | 72,879,738 | 66,949,958 |
Accumulated deficit | (68,797,872) | (63,674,531) |
Total Stockholders’ Equity | 4,083,529 | 3,276,494 |
Common Stock | 1,663 | 1,067 |
Additional Paid In Capital | 72,879,738 | 66,949,958 |
Accumulated Deficit | (68,797,872) | (63,674,531) |
Total Liabilities and Stockholders’ Equity | 4,736,605 | 5,732,804 |